Feasibility and Safety of Anlotinib Combined with Immune Checkpoint Inhibitors in Patients with Previously Immunotherapy-Treated Extensive-Stage Small Cell Lung Cancer: A Retrospective Exploratory Study

Chen TF, Li ZJ, Zhao HS, Yang R

Drug Design, Development and Therapy 2025, 19:4991-5005

Published Date: 9 June 2025